Acute intermittent porphyria: The in vitro expression of mutant hydroxymethylbilane synthase

Molecular and Cellular Probes

Volumn 11, Issue 4, 1997, Pages 293-296

  Ong, Patricia M L ^a   Lanyon, W George ^a   Graham, Gordon ^a   Hift, Richard J ^b   Halkett, Janet ^b   Moore, Michael R ^c   Connor, J Michael ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Acute intermittent porphyria; Hydroxymethylbilane synthase; In vitro expression; Specific activity

Indexed keywords

PORPHOBILINOGEN DEAMINASE;

ACUTE INTERMITTENT PORPHYRIA; ARTICLE; CASE REPORT; DNA SEQUENCE; GENE SEQUENCE; HUMAN; MISSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0030866986     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcpr.1997.0118     Document Type: Article

References (14)

1. Kappas A, Sassa S, Galbraith R. A, Nordmann Y. The Porphyrias. InThe Metabolic Basis of Inherited Disease. New York: McGraw Hill. 6:1989;1305-1365.
2. Louie G. V, Brownlie P. D, Lambert R. The three-dimensional structure ofEscherichia coli. Proteins: Structure, Function and Genetics. 25:1996;48-78.
3. Brownlie P. D, Lambert R, Louie G. V. The three-dimensional structures of mutants of porphobilinogen deaminase: toward an understanding of the structural basis of acute intermittent porphyria. Protein Science. 3:1994;1644-1650.
4. Pakula A. A, Sauer R. T. Genetic analysis of protein stability and function. Annual Review of Genetics. 23:1989;289-310.
5. Alber T. Mutational effects of protein stability. Annual Review of Biochemistry. 58:1989;765-798.
6. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Analytical Biochemistry. 162:1987;156-159.
7. Mgone C. S, Lanyon W. G, Moore M. R, Connor J. M. Detection of seven point mutations in the porphobilinogen deaminase gene in patients with acute intermittent porphyria by direct sequencing ofin vitro. Human Genetics. 90:1992;12-16.
8. Cotton R. G. H, Rodrigues N. R, Campbell R. D. Reactivity of cytosine and thymine in single base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations. Proceedings of the National Academy of Sciences, USA. 85:1988;4397-4401.
9. Sanger F, Nicklens S, Coulson A. R. DNA sequencing with chain terminating inhibitors. Proceedings of the National Academy of Sciences, USA. 74:1977;5463-5467.
10. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
11. De Rooij F. W. M, Hamer C. M, Wilson J. H. P. Purification of porphobilinogen deaminase from human erythrocytes by fast protein liquid chromatography. Clinica Chimica Acta. 162:1987;61-68.
12. Llewellyn D. H, Whatley S, Elder G. H. Acute intermittent porphyria caused by an arginine to histidine substitution (R26H in the cofactor-binding cleft of porphobilinogen deaminase. Human Molecular Genetics. 2:1993;1315-1316.
13. Lee J-S. Molecular Genetic Investigation of the Human Porphobilinogen Deaminase Gene in Acute Intermittent Porphyria. Stockholm: Repro Print. 1991;1-50.
14. Delfau M. H, Nordmann Y, Grandchamp B. Two different point G to A mutations in exon 10 of the porphobilinogen deaminase gene are responsible for acute intermittent porphyria. Journal of Clinical Investigation. 86:1990;1511-1516.